The importance of having nanoparticles that are soluble, stable, and that have no non-specific binding is often overlooked, but essential for their use in biology. This is particularly prominent with silver nanoparticles that are susceptible to effects of aggregation and metal-surface reactivity. Here we use a combination of several small peptidols and short alkane-thiol ethylene glycol ligands to develop a ligand shell that is reasonably resistant to ligand exchange and non-specific binding to groups common in biological molecules. The stability of the nanoparticles is not affected by the inclusion of a functional ligand, which is done in the same preparative step. The stoichiometry of the nanoparticles is controlled, such that monofunctional silver nanoparticles can be obtained. Two different sets of nanoparticles, functionalized with either Trisnitriloacetic acid or a hexa-histidine peptide sequence, readily form dimers / oligomers, depending on their stoichiometry of functionalization.
Introduction
The emergence of new analytical techniques based on nanomaterials with application to the understanding of biological problems has inspired the development of sensors able to interact with biological molecules. Sensors attached to these biomolecules utilize these new techniques to enhance sensitivity and specificity of detection. [1] Quantum dots, noble metal nanoparticles, and superparamagnetic iron oxide nanoparticles are among the favorite materials for nano-sized sensors. Noble metal nanoparticles have been used since 1971 for the labeling of proteins for observation by electron microscopy. [2] These have become more attractive in recent years due to an increased variety of applications that take advantage of their optical properties. [3] [4] [5] This includes localized surface plasmon resonance, [6, 7] photothermal microscopy, [8] photoacoustic tomography, [9, 10] surfaceenhanced Raman scattering [11] and surface enhanced fluorescence. [12, 13] These applications rely on the interaction of noble metal nanoparticles with light, causing an oscillation of electrons on the nanoparticle surface, [14] which at the resonant frequency generates a very strong electromagnetic field. This is stronger with silver than gold nanoparticles. Silver nanoparticles are better absorbers and scatterers of light, have sharper resonance peaks due to a longer plasmon lifetime, and higher refractive index sensitivity than gold nanoparticles. This makes silver nanoparticles preferable for some of the applications mentioned above. However, the major limitation of silver nanoparticles compared to gold nanoparticles is their stability, involving aggregation, and the metal-surface reactivity (i.e. oxidation). The challenge is thus to overcome this hurdle.
The peptide Cys-Ala-Leu-Asp-Asp (H-CALNN-OH) has been successfully used previously as a capping ligand for both gold [15] and silver nanoparticles, [16] forming a dense and stable self-assembled monolayer. The colloidal stability imparted by this peptide relies greatly on the C-terminal carboxylic acid, which provides electrostatic repulsion between nanoparticles. The downside of this approach is that H-CALNN-OH capped nanoparticles have been shown to bind to positively charged patches on biological molecules, resulting in non-specific binding; [17] indeed this effect has been used as a means to detect basic heparin-binding peptides. [18] Alkane-thiols terminated by ethylene glycol units have also been used to form self-assembled monolayers with gold [19] [20] [21] and silver [16, 22] nanoparticles. Terminal ethylene glycol units have not been as simple to functionalize as when using peptides [23] [24] [25] [26] but recent progress has significantly improved on this. [22] ssDNA has also been used to cover silver nanoparticles. [27] [28] [29] [30] While this does provide some advantages in terms of functionalization, there is substantial potential for non-specific binding of DNAbinding proteins. Mixtures of alcohol-terminated peptides (peptidols) and alkane-thiol terminated with ethylene glycol have been shown to provide excellent stabilization of gold nanoparticles, resistance to non-specific binding, whilst maintaining the versatility of functionalization of the ligand shell system. [17] Controlling the functionalization of nanoparticles to a single ligand is of interest in both increasing sensitivity for a single molecule probe system or for the organization of nanoparticles in solution; the simplest example being a dimer.
Quo et al. have been prominent in obtaining high yields of monofunctional gold nanoparticles and gold dimers by introduction of single carboxylic-acid molecules onto gold nanoparticles. [31] [32] [33] Their nanoparticles and some other examples in the literature [34, 35] are soluble in organic solvents, since they are capped with alkane-thiol self-assembled monolayers, so in the current form are not suitable for deployment in biological environments. The formation of silver and gold nanoparticle dimers has also been achieved by controlled aggregation using electrolytes. [36, 37] However, the formation of aggregates in the latter examples relies on there not being a stable and densely packed self-assembled monolayer surrounding the nanoparticles, which is a key requirement for application of materials to biological problems. The interest in plasmon coupling has led to the development of gold and silver nanoparticle dimers and heterodimers. [38] [39] [40] [41] [42] [43] For these dimers, considerable progress has been made using hybridization of single-stranded DNA-linked nanoparticles with the use of ethylene glycol ligands to provide good colloidal stability. [40] [41] [42] In this work we synthesize silver nanoparticles with a mixed ligand shell that provides stability and resistance to nonspecific binding for use in biological environments. Additionally, a control of functionalization down to single monofunctional nanoparticles is achieved. Using complementary functional ligands, the conjugation of silver nanoparticles forming dimers and oligomers is demonstrated.
Results and Discussion

Ligand capping of silver nanoparticles
A mixture of a peptidol and an ethylene glycol terminated alkane-thiol ligand has been shown to stabilize gold nanoparticles effectively. [17] In a first set of experiments, mixtures of the peptidol H-CVVVT-ol with the ligand HS-(CH 2 ) 11 -EG 4 were used to determine if they were as effective at stabilizing silver as gold nanoparticles. Previous methods for capping silver [16] and gold [15, 17] nanoparticles used a phosphate-buffered saline buffer in the ligand capping solution to promote self-assembly of the ligand shell. However, we found that these conditions were not effective. In any nanoparticle preparation produced by reduction there are always unreacted metal cations remaining. The ion Ag + is poorly soluble in the presence of chloride or phosphate anions and the resulting precipitates may have compromised the assembly of the ligand shell on the silver nanoparticles. Therefore, we used sodium nitrate and buffered the pH with HEPES. Mixtures of HS-(CH 2 ) 11 -EG 4 with H-CVVVT-ol were prepared from an 8:2 ratio (20% H-CVVVT-ol) to a 2:8 ratio (80% H-CVVVT-ol) in steps of 20% (all mole/mole). These ligands were mixed with silver nanoparticles and agitated overnight with 100 mM NaNO 3 , 20 mM HEPES, pH 7.4. After washing by centrifugation their stability in 1 M NaCl was assessed. The position of the plasmon absorbance was unchanged across the different ligand ratios tested (Fig.  1) , though the intensity of absorbance increased a little, probably due to the purification by centrifugation or the quality of synthesised nanoparticles. The ligand shell HS-(CH 2 ) 11 -EG 4 :H-CVVVT-ol 6:4 (mole/mole) produced the most stable nanoparticles for the lowest content of HS-(CH 2 ) 11 -EG 4 (Fig. S1 ). This is different from the ratios found for gold nanoparticles. [17] It was decided to chose nanoparticles with the lowest proportion of HS-(CH 2 ) 11 -EG 4 in the capping ligand mixture for the rest of the study, since ethylene glycol can interfere with biological functions grafted onto nanoparticles. [24] 
Stability and non-specific binding of purified nanoparticles
For further stability tests and functionalization, nanoparticles were obtained from nanoComposix, Inc (San Diego, USA) and the purification method changed. To demonstrate the generality of our approach, a second peptidol sequence was also used, H-CALNN-ol, at the same HS-(CH 2 ) 11 -EG 4 :peptidol 6:4 ratio of capping ligands. The silver nanoparticles could thus be purified from excess ligand and buffer exchanged by size-exclusion chromatography with Sephadex G25 (Fig. 2a) . The highest recovery of silver nanoparticles was found when the running buffer contained electrolytes (100 mM NaCl in this instance) and the surfactant Tween-20 (0.005% v/v). Nanoparticles prepared and purified this way could be used as is, or exchanged to water or buffer by centrifugation using Nanosep 30K filters and washing the nanoparticles three times with the required solution.
The purified nanoparticles were again tested for their stability to high concentrations of electrolytes (1 M NaCl). Stability against electrolyte-induced aggregation of HS-(CH 2 ) 11 -EG 4 : peptidol 6:4 (mole/mole) nanoparticles was determined by incubating the nanoparticles for 16 hours at room temperature with phosphate-buffer saline (PBS) containing 1 M NaCl. It is noted that capped and washed silver nanoparticles are stable in PBS. Nanoparticles with HS-(CH 2 ) 11 -EG 4 :H-CVVVT-ol 6:4 (mole/mole) and HS-(CH 2 ) 11 -EG 4 :H-CALNN-ol 6:4 (mole/mole) remained stable, as indicated by their UV-vis spectra (Fig. 3) . As an indication of the excellent long term stability of the nanoparticles, the representative graph of electrolyte-stability of HS-(CH 2 ) 11 -EG 4 :H-CVVVT-ol 6:4 (mole/mole) ( Fig. 3b) is that of nanoparticles prepared 5 months previously and stored at 4°C. A critical test of stability of metal nanoparticle ligand shells is their resistance to ligand-exchange. This was achieved by measuring the susceptibility of the nanoparticles to degradation by cyanide ions. Cyanide ions, will readily dissolve non-passivated or insufficiently protected gold or silver nanoparticles. In the presence of 10 mM NaCN (Fig. 4) , H-CALNN-OH protected gold nanoparticles are mostly dissolved, whereas HS-(CH 2 ) 11 -EG 4 :H-CVVVT-ol 3:7 (mole/mole) gold nanoparticles are almost completely resistant to dissolution and hence ligand-exchange, in agreement with previous observations. [24] Over 80% of silver nanoparticles with a HS-(CH 2 ) 11 -EG 4 :H-CVVVT-ol 6:4 (mole/mole) or HS-(CH 2 ) 11 -EG 4 :H-CALNN-ol 6:4 (mole/mole) monolayers were also resistant to dissolution by cyanide; just 16% and 19%, respectively, of the nanoparticles were dissolved.
Chromatography on Sephadex G25 provides an insight into an aspect of the resistance of the nanoparticles to non-specific binding. The large number of hydroxyl groups on Sephadex G25 (cross-linked dextran) are a mimic for an important functional group present on biological molecules. An absence of non-specific binding to Sephadex G25 indicates a likely resistance of the nanoparticles to interaction with these groups. As a further set of tests for non-specific binding of nanoparticles, two ion-exchange resins were used as mimics of other species found on biologcal molecules: the anionexchange resin diethylaminoethyl(DEAE)-Sepharose contains a high density of amines, whereas the cation-exchange resin carboxymethyl(CM)-Sepharose contains a high density of carboxyl groups. For testing of binding to DEAE-Sepharose or CM-Sepharose, the nanoparticles were exchanged into PBS using Nanosep 30K filters, by washing the nanoparticles three times with PBS, and incubated with agitation for at least 2 hours. Results obtained from three separate nanoparticle experiments (Fig. 2b) showed that 97.6 ± 2.5% of the nanoparticles did not bind to DEAE-Sepharose, and 96.5% ± 2.3% of the nanoparticles did not bind to CM-Sepharose. Thus, these nanoparticles do not interact detectably with either of these ion-exchange resins. These nanoparticles also do not bind to several affinity chromatography resins we tested, a hexa-histidine functionalized Affi-10 resin (Fig. 5a ) and Probond resin (Fig. 5c) . Therefore, the silver nanoparticles with the mixed ligand shell are not just stable to electrolyteinduced aggregation and ligand-exchange, but also in a variety of chromatographic scenarios. This means that they can be handled as a standard biochemical in the course of subsequent biofunctionalization, as well as suggesting that they are likely to be resistant to substantial, if not all, non-specific binding in biological environments. Fig. 3 . UV-vis spectra of (a) HS-(CH2)11-EG4:H-CALNN-ol 6:4 (mole/mole), and (b) HS-(CH2)11-EG4:H-CVVVT-ol 6:4 (mole/mole) nanoparticles either in water (clear boxes -selected points only) or after 16 hour incubation with 1 M NaCl in PBS at room temperature (black line).
Nanoparticles containing one or more functional ligand in the self-assembled monolayer
The synthesis of nanoparticles with a single functional ligand is performed statistically. This approach requires the use of an affinity chromatography support able to bind nanoparticles containing functional ligand incorporated within the selfassembled monolayer. The dilution of a functional ligand into the ligand mixture used to form a self-assembled monolayer that results in 10% or less of the nanoparticles binding to the affinity gel, corresponds to the dilution yielding nanoparticles with just one functional ligand. [44] The percentage of nanoparticles that bind the affinity chromatography resins was determined by the proportion of nanoparticles that do not bind to the resin, as measured by UV-visible spectrophotometry (Fig. 5a and 5c ). This was also observed qualitatively by the settling of the affinity resin in the tube (Fig. 5b) .
Two functional ligands were chosen. The first, trinitrilotriacetic acid (Tris-NTA), binds strongly to a six histidine sequence of amino acids. [45] [46] [47] Such amino acid sequences are often added to recombinant proteins to aid in their purification or labeling. An affinity resin able to bind to Tris-NTA was synthesized by conjugation of the peptide H-CVVVTGGGHHHHHH-OH (CVVVT-H6) to Affi-10 resin to produce hexa-histidine resin. The Tris-NTA ligand, an alkanethiol-ethylene glycol functionalized with a trinitrilotriacetic acid [HS-(CH 2 ) 16 -EG 3 -tri-nitrilotriacetic acid], has been shown to be well incorporated into the capping of gold nanoparticle shells to provide single Tris-NTA ligand, and so 1:1 stoichiometry of nanoparticle functionalization. [17] The peptide CVVVT-H6 was chosen as the second functional ligand. Nanoparticles containing this ligand were purified using a metal-ion affinity chromatography resin (IMAC). HS-(CH 2 ) 11 -EG 4 :H-CALNN-ol 6:4 (mole/mole) were used for the incorporation of Tris-NTA ligand, and HS-(CH 2 ) 11 -EG 4 :H-CVVVT-ol 6:4 (mole/mole) nanoparticles were used for the incorporation of the CVVVT-H6 peptide ligand. Fig. 5a shows the percentage of binding of Tris-NTA functionalized nanoparticles to hexa-histidine resin. Fig. 5b shows the binding of these nanoparticles to the resin. The percentage of binding of CVVVT-H6 functionalized nanoparticles to Probond IMAC resin is shown in Fig. 5c . Monovalently functionalized nanoparticles containing either 0.03% (mole/mole) of CVVVT-H6 peptide in the ligand capping, or 0.002% (mole/mole) of Tris-NTA ligand in the ligand capping were recovered from their respectively bound affinity chromatography support as follows: the affinity resin with bound nanoparticles were mixed with 1 resin volume of 200 mM imidazole in PBS. The resin was allowed to settle, and the supernatant removed. The supernatant contains the nanoparticles. This process was repeated twice to ensure full recovery of nanoparticles, and the samples pooled together. Purified monovalently functionalized nanoparticles were buffer-exchanged by centrifugation on a 30 K Nanosep filter. Multivalently functionalized nanoparticles with between approximately 1 and 3 functional ligands per nanoparticle (between 40 -60 % binding of a nanoparticle preparation to their respective affinity resin) were also prepared and purified this way.
Functional group-driven nanoparticle oligomerization
To demonstrate functionality on the nanoparticles, we decided to look at the binding between nanoparticles to form dimers and oligomers using the complimentary functionalized silver nanoparticles. IMAC binding of the purified monofunctional nanoparticles was complete (Fig. S2) with no nanoparticles present in the supernatant as measured by UV-visible spectrophotometry, indicating that the nanoparticles do indeed all contain a functional ligand. Similar results are obtained with nanoparticles containing one or more functional ligand. Thus, the monovalently / multivalently functionalized Tris-NTA and hexa-histidine silver nanoparticles provide a means to synthesize nanoparticle oligomers. Since hexa-histidine sequences are commonly used to aid the purification of recombinant proteins, then the silver nanoparticle carrying a hexa-histidine tag can be considered to be a proxy for such a protein. The formation of oligomers between nanoparticles functionalized with hexa-histidine and Tris-NTA would thus indicate that the latter could be used to capture a hexahistidine tagged recombinant protein.
TEM was used to show the formation of dimers / oligomers. To demonstrate specific interaction, as opposed to nonspecific nanoparticle aggregation, we used the nanoparticles with 1-3 functional groups. This is because the signal (nanoparticles interact specifically due to functionalization) to noise (nanoparticles interact due to lack of stability) is lower with mono-functionalized nanoparticles. This ensures that more nanoparticles can form dimers / oligomers through interaction of their Tris-NTA / hexa-histidine functional groups. Tris-NTA functional nanoparticles (Fig 6a and S4 ) and hexa-histidine functional nanoparticles ( Fig. 6b and S5 ), even after storage for at least two weeks, are clearly monomers. In contrast, when these two types of nanoparticles are mixed many oligomers are formed (Fig. 6c and S6) , a process clearly due to the functional groups rather than any instability of the nanoparticles. Initial tests of mixing together the complementary mono-functional nanoparticles at the same volume and concentration ( max of the final solution at 0.6) gave approximately 33% of dimers (based upon the number of nanoparticles counted in a TEM image of 196 - Fig. S3 ). 
Conclusions
Here we synthesize silver nanoparticles with a mixed ligand self-assembled monolayer that imparts excellent solubility in aqueous solutions, stability to high electrolyte concentrations and a good resistance to cyanide-mediate dissolution of the metal core compared to peptide-capped gold nanoparticles. Also, these nanoparticles do not bind to various ion-exchange and other chromatography resins, thus showing low nonspecific binding properties. The HS-(CH 2 ) 11 -EG 4 :H-CALNNol and HS-(CH 2 ) 11 -EG 4 :H-CVVVT-ol coated silver nanoparticles prepared are thus compatible with a biological environment and suitable for development of biosensors. To show that functional ligand incorporation can be used to attach these nanoparticles to biomolecules, we used complementary functional ligands in silver nanoparticles to form nanoparticle oligomers. We are also able to produce dimers by the mixing of monofunctional silver nanoparticles. Dimer formation was estimated at 33%. Why the reaction has not gone to completion is not yet known and is the subject of future studies, but may in part be due to the low concentration of nanoparticles. Others have shown higher conjugation efficiencies to form dimers, [35, 48] however, in the present case, the nanoparticles are entirely compatible with biological systems and reagents. This means that purification of the dimers is straightforward: the Tris-NTA:hexa-histidine conjugate does not readily exchange due to a reduced dissociation rate constant [45] [46] [47] (so the dimers will not bind to the respective affinity resins IMAC and hexa-histidine), whereas the unreacted nanoparticles will.
Theoretical and experimental studies indicate that the area between adjacent nanoparticles, called 'hot spots', has a greatly enhanced electromagnetic field. This effect is particularly evident with silver nanoparticles. [12, 13, 49] Hot spots are more likely to be present for dimers using larger sized silver nanoparticles than those we use here. For example, ~ 41 nm silver nanoparticles joined by ssDNA hybridization has yielded much information about plasmon coupling of dimers. [41] Peptide chemistry, like DNA, allows precise control of interparticle distances. Since peptide structure and hence inter nanoparticle distance can be controlled by biochemical reactions (proteolysis, phosphorylation etc.) and the nanoparticles are particularly stable and resistant to nonspecific binding, the present materials offer the possibility of developing biosensors that would function in living systems. We also note that the high stability of our nanoparticles allows chromatography and ultimately lateral filtration separation approaches and so is thus scalable. Thus, the versatility of our ligand shell, coupled to the choice of nanoparticle types, [17] and functional ligands, provides the potential flexibility for future development of larger sized silver nanoparticles for dimer / oligomer formation and nanoparticle sensor applications.
Experimental
Materials
Peptidols H-CALNN-ol, H-CVVVT-ol (N-ol is for asparaginol and T-ol is for threoninol) and peptide H-CVVVTGGGHHHHHH-OH (termed CVVVT-H6) were obtained from Peptide Protein Research Ltd. (Fareham, UK). Ethyleneglycol(EG)-derived alkane-thiol, HS-(CH 2 ) 11 -EG 4 , Mw 380 was purchased from Prochimia (ProChimia Surfaces Sp. z o.o., Sopot, Poland). HS-(CH 2 ) 16 -EG 3 -tri-nitrilotriacetic acid (referred to as Tris-NTA) was a gift from R. Tampé (Johann Wolfgang Goethe University, Frankfurt, Germany). Silver nanoparticles used during initial test of ligand mixes for peptidol / HS-(CH 2 ) 11 -EG 4 ratios (Fig. 1) were synthesis as the Doty et al. method, [16] and explained below. Silver nanoparticles for all subsequent work were 8.4 ± 1.5 nm, in 2 mM citrate (10nm nanoXact), obtained from nanoComposix, Inc (San Diego, USA). Sodium nitrate, Tween-20, 10 x sodium phosphate buffer (referred to as 10 x PBS: 81 mM Na 2 HPO 4 , 12 mM, KH 2 PO 4 , 1.4 M NaCl, and 27 mM KCl, pH 7.4) and 4-(2-hydroxyethyl) piperazine-1-ethanesulfonic acid (HEPES) were obtained from Sigma Aldrich Pte Ltd (Singapore). PBS buffer is obtained by a 10 times dilution of 10 x PBS buffer in purified water, adjusted to pH 7.4. All aqueous solutions contain 0.005% (v/v) of the surfactant Tween-20. All water used was of MilliQ-quality standard. Nickel (II) nitrate hexahydrate (Alfa Aesar) and Nanosep 30K filters (Pall) were obtained from VWR Singapore Pte Ltd (Singapore). TEM Grids were obtained from Pelco International (Redding, USA). Sephadex G25 Fine, Diethylaminoethyl (DEAE) Sepharose Fast Flow and Caboxymethyl (CM) Sepharose Fast Flow (GE Healthcare) were obtained from SciMed (Asia) Pte Ltd (Singapore). Nickel chelating resin (Probond resin) was obtained from Invitrogen (Paisley, UK). Affi-10 resin and Econo-Pac 1.5cm x 14cm chromatography columns were obtained from BioRad Laboratories (Singapore) Pte Ltd (Singapore).
Silver nanoparticle synthesis
Silver nanoparticles were synthesized as per the method of Doty et al., [16] briefly, to a 200 mL solution of AgNO 3 (0.25 mM) and trisodium citrate (0.25 mM) was added an aqueous solution of NaBH 4 (6 mL, 10 mM) and the reaction stirred for 30 min. The yellow colloidal silver solution that formed was then left undisturbed overnight.
Peptide and nanoparticle ligand-capping stock preparation
H-CALNN-ol and H-CVVVT-ol peptide stocks were prepared at 4 mM in 25%:75% dimethylsulphoxide (DMSO):MilliQquality purified water. These stocks were diluted to 2 mM with water. HS-(CH 2 ) 11 -EG 4 stocks at 100 mM in ethanol were first diluted to 5 mM with ethanol and then to 2 mM with water. H-CVVVTGGGHHHHHH-OH stocks were stored at 5 mM in DMSO, and diluted to 2 mM or lower in water. Tris-NTA was diluted to 5 mM stocks and lower concentrations in ethanol. All stocks were kept as aliquots at -20ºC.
Ligand-capping of silver nanoparticles
Self-assembled monolayers on silver nanoparticles were formed by adding 10 volumes of stock nanoparticles to 1 volume of 2 mM capping ligand. Ligand capping mixes used in initial experiments were of ratios (mole/mole) from 2:8 to 8:2 (in steps of 20%) of HS-(CH 2 ) 11 -EG 4 to H-CVVVT-ol. All other tests used ligand capping mixes of either HS-(CH 2 ) 11 -EG 4 :H-CALNN-ol 6:4 (mole/mole), or HS-(CH 2 ) 11 -EG 4 :H-CVVVT-ol 6:4 (mole/mole). After 2 min, the solution was adjusted to 100 mM NaNO 3 , 20 mM HEPES, 0.005% (v/v) Tween-20, pH 7.4. The nanoparticle solutions were mixed gently overnight to allow full self-assembly of the ligand shell.
Preparation of nanoparticles with functional ligand
For addition of either of the functional ligands Tris-NTA or H-CVVVTGGGHHHHHH-OH (CVVVT-H6) peptide into the ligand-capping mix, the required molar ratio of functional ligand was added to the ligand-capping mix before addition of the silver nanoparticles. For Tris-NTA-incorporated nanoparticles, after overnight agitation of the nanoparticle solution, a final concentration of 250 mM nickel nitrate was added to the nanoparticles and agitation continued for 2 hours.
Purification of ligand-capped nanoparticles
Purification to remove unreacted ligands, salts, and where appropriate nickel salts, was performed initially by centrifugation (Eppendorf 5418 centrifuge with 7.7 cm radius rotor) at 12,000 rcf for 1 hour, removing the supernatant and resuspending in water. This step was repeated twice, with the final resuspension into water. In other experiments purification was accomplished by Sephadex G25 sizeexclusion chromatography with a mobile phase of 100 mM NaCl and 0.005% (v/v) Tween-20. Depending on purification volume, a standard 1.5 cm x 14 cm column (Econo-Pac, BioRad Laboratories (Singapore) Pte Ltd) or XK 26 / XK 50 column (GE Healthcare, supplied by SciMed (Asia) Pte Ltd) were used. Nanoparticles were exchanged into PBS by the use of Nanosep 30K filters, washing the nanoparticles three times with PBS by centrifugation for 3 min at 12,000 rcf.
UV-Visible Spectrophotometry and Transmission Electron Microscopy
Absorption spectra were recorded at room temperature using a SpectraMax Plus spectrophotometer (Molecular Devices, Wokingham, UK). For spectra, samples of nanoparticles were diluted to give an absorbance between 0.5 and 1 A.U. for the  max of the silver nanoparticles. Normalized spectra were obtained from spectrum recorded between 320 nm and 600 nm. Transmission Electron Microscopy was performed on carbon coated copper grid (cat # 01824, Ted Pella) using an xFEI Titan with a Schottky-type electron gun, operated at 200kV (FEI, Oregon, USA), or with a Philips 300kV TEM.
Electrolyte-induced aggregation
NaCl to a final concentration of 1 M was added to ligandcapped nanoparticles in PBS. Nanoparticles were left to stand for 16 h at room temperature before UV visible spectra were recorded. UV visible spectra of nanoparticles in water were also recorded as a control.
Cyanide-mediated dissolution of nanoparticles
NaCN to a final concentration of 10 mM was added to ligandcapped nanoparticles in PBS, pH 9.0. Nanoparticles were left to stand for 1 h at room temperature before UV visible spectra were recorded. UV visible spectra of nanoparticles in just PBS, pH 9.0 were also recorded. The percentage of dissolved nanoparticles was calculated from the ratio of the absorbance at  max of the NaCN-treated (T) and control nanoparticles without cyanide (C) as follows: (100 -[(T/C) x 100]) %.
Binding of nanoparticles to ion-exchange resins
DEAE-Sepharose and CM-Sepharose were prepared, as specified by the manufacturer, and equilibrated into PBS. Capped nanoparticles (90 μL) in PBS were added to 20 μL of DEAE-Sepharose or CM-Sepharose in a 0.5 mL centrifuge tube. After 1 hour of incubation with agitation, the resin was allowed to sediment. A control was also run for each sample and resin, substituting the resin solution for PBS. The percentage of bound nanoparticles to a resin was calculated from the ratio of the absorbance at  max of the supernatants from resin-treated (R) and control nanoparticles without resin (C) as follows: (100 -[(R/C) x 100]) %.
Preparation of the hexa-histidine resin
Affi-10 resin slurry (2 ml) was washed with 10 mL of cold (4 °C) 1 mM HCl, and then twice with DMSO, to give approximately 1 mL of resin. To this was added 950 μL of DMSO, and 50 μL of CVVVT-H6 peptide (5 mM, in DMSO). The reaction was stirred overnight at room temperature before adding 6 mL 100 mM Tris-HCl, pH 8.5 for 4 h to block unreacted N-hydroxysuccinimide groups. The resin was washed three times alternately with 50 mM sodium acetate, 0.5 M NaCl, pH 4.5, and then with 100 mM Tris-HCl, pH 8.5. The resin was stored at 4 °C in 20% (v/v) ethanol / water until further use.
Purification of functional nanoparticles
Nanoparticles containing Tris-NTA ligand, or CVVVT-H6 peptide were purified by affinity chromatography using hexahistidine resin or Probond, respectively. Resin (0.1 volume) was added to 1 volume of nanoparticles in PBS and agitated for 2 h at room temperature. Unbound nanoparticles, i.e. those containing no functional ligand, were removed by washing the resin solution in a column with 10 volumes of PBS. Resin was then transferred to 1.5 mL tubes, and nanoparticles eluted by thoroughly mixing the resin with 0.1 volume of PBS containing 200 mM imidazole. After the resin settled, the supernatant containing the monofunctional nanoparticles was removed. This process was repeated twice to ensure full recovery of nanoparticles. For nanoparticles containing CVVVT-H6 peptide, removal of the imidazole and exchange of the solution to PBS was performed using Nanosep 30K filters, by first washing once with water, and then three times with PBS. For Tris-NTA containing nanoparticles, the Tris-NTA was also re-loaded with nickel. First the imidazole was removed and the nanoparticles exchanged into 100 mM NaCl using G25 Sephadex. Nanoparticles were then incubated with 250 mM nickel nitrate with agitation for 2 h. Purification of the nanoparticles was again by G25 Sephadex, followed by transfer to PBS buffer using Nanosep 30K filters by washing three times with PBS.
Conjugation of monofunctional nanoparticles
Monofunctional nanoparticles (50 μL of) containing Tris-NTA ligand and 50 μL of monofunctional nanoparticles containing CVVVT-H6 peptide ligand (both in PBS) were mixed together in a 0.5 mL centrifuge tube at equimolar concentrations (final absorbance of  max at 0.6) and agitated for 24 h. The nanoparticles were washed twice in water using Nanosep 30K filters, and resuspended to 30 μL in water. Analysis of the nanoparticles was by TEM.
